Author

Mario Delgado

Consejo Superior de Investigaciones CientíficasORCID 0000-0003-1893-5982Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Molecular Biology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Elena González‐ReyiD· 2 shared A. Destée· 1 shared Alberto Bergareche‐Yarza· 1 shared Álvaro Rol· 1 shared Amélie Vizeneux· 1 shared Ana Vinagre‐AragóniD· 1 shared Anna Escolà· 1 shared Antoni RiéraiD· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioinformatics

Elena González‐ReyORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BioinformaticsbioRxivPreprintJul 12, 2023

reanalyzerGSE: tackling the everlasting lack of reproducibility and reanalyses in transcriptomics

José Luis Ruiz, Laura Carmen Terron-Camero, Julia Castillo-González…·Eduardo Andrés‐León

reanalyzerGSE provides a pipeline for reproducible and standardized reanalysis of transcriptomic data from local and public sources.

5 citations

bulk RNA-seqstatistical model

𝕏 PostBluesky

NeurosciencebioRxivPreprintApr 11, 2023

A potential patient stratification biomarker for Parkinson's disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells

Yahaira Naaldijk, Belén Fernández, Rachel Fasiczka…·Sabine Hilfiker

Peripheral blood-derived cells can be employed to stratify Parkinson's disease patients most likely to respond to LRRK2-related therapeutics.

1 citation

humanproteomics

𝕏 PostBluesky

Molecular BiologybioRxivPreprintNov 20, 2019

Structure-based design of a Cortistatin analog with improved immunoregulatory activity against inflammatory bowel disease (IBD)

Álvaro Rol, Toni Todorovski, Pau Martín-Malpartida…·María Jesús Macías

The paper designs a Cortistatin analog with improved immunoregulatory activity for treating inflammatory bowel disease by optimizing its structure and stability.

DOI 10.1101/839787

experimental assaydrug response / drug discovery

𝕏 PostBluesky